Verrica Pharmaceuticals (VRCA) Q4 2024 Earnings

4NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.56
-0.5
-0.43
-0.37

Details

Expected EPS
-0.3763
Actual EPS
-0.49
Surprise EPS
-0.11
Surprise Percent
+30.22%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.49 per share for Q4 2024.

0 Comments

Share your thoughts